|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2600 CAD | 0.00% |
|
+8.33% | +1.96% |
| 21/05 | Vext Science, Inc., Q1 2026 Earnings Call, May 21, 2026 | |
| 21/05 | Vext Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 46.15 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | -1.14% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 32.25 | 46.25 | 58.25 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | -30.91% | 43.41% | 25.94% |
| P/E ratio | - | - | 7.07x | -1.43x | -2.66x | -18.6x | 18.6x | -18.6x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.86x | 0.67x | 0.62x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.6x | 0.67x | 0.79x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 2.07x | 2.34x | 2.65x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | 161x | 11.3x | - |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | 5.73x | 3.43x | 2.61x | 2.97x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | 17.4% | 29.2% | 38.4% | 33.7% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | -0.014 | 0.014 | -0.014 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 53.8 | 68.95 | 74 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 15.6 | 19.8 | 22 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | 0.2 | 4.1 | - |
| Net income 1 | - | - | - | - | -17.99 | -2.3 | 2.37 | -1.6 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | -13.9 | 0.1 | 12.1 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2600 | 0.2600 | 0.2600 |
| Nbr of stocks (in thousands) | 1,36,713 | 1,48,963 | 2,17,484 | 2,47,443 | 2,51,034 | 2,47,684 | - | - |
| Announcement Date | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | 29/04/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -18.57x | 0.6x | 2.07x | - | 4.62Cr | ||
| 11.62x | - | - | - | 15Cr | ||
| 13.38x | - | - | - | 12Cr | ||
| -1.37x | 0.69x | 3.03x | - | 11Cr | ||
| -2.07x | 1.13x | 6.16x | - | 10Cr | ||
| Average | 0.60x | 0.81x | 3.75x | 10.53Cr | ||
| Weighted average by Cap. | 4.01x | 0.85x | 4.09x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VEXT Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















